Jim Cramer discussed his stock picks on CNBC’s Mad Dash segment.
Cramer said Fed Chief Janet Yellen made the worst stock call he has ever heard when she made bearish statement about the biotech sector this summer. “She called the bottom (in the sector). Thank you Janet Yellen. Never talk about stocks again … that may be as bad a call as I’ve ever seen in my lifetime.”
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
He liked Biogen, whose MS drug is outperforming, and it has a promising early stage Alzheimer’s treatment. Celgene is inexpensive, Regeneron has a healthy pipeline. He would wait on Gilead, because some information is coming out about a competing Hepatitis C drug.
Cypress is merging with Spansion and is getting into the internet of things. He predicted a breakout quarter for the stock without the deal, but believes this news should take it higher. Cramer gives all the credit to Cypress CEO T.J Rodgers, “I love him. I love the stock.”
